Smart For Life, Inc. SMFL
We take great care to ensure that the data presented and summarized in this overview for SMART FOR LIFE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SMFL
Top Purchases
Top Sells
About SMFL
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
Insider Transactions at SMFL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Hrt Financial LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
39,093
-85.66%
|
$0
$0.86 P/Share
|
|
Sep 10
2024
|
Hrt Financial LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
23,962
+34.43%
|
$0
$0.89 P/Share
|
|
Sep 09
2024
|
Hrt Financial LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,722
+44.98%
|
$0
$0.94 P/Share
|
|
Sep 06
2024
|
Hrt Financial LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
23,811
-85.77%
|
$23,811
$1.03 P/Share
|
|
Sep 05
2024
|
Hrt Financial LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,991
-17.75%
|
$5,991
$1.08 P/Share
|
|
Dec 16
2022
|
Trilogy Capital Group, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,161,000
-18.17%
|
$0
$0.26 P/Share
|
|
Dec 16
2022
|
Alfonso J. Cervantes Jr Executive Chairman |
SELL
Open market or private sale
|
Indirect |
1,161,000
-18.17%
|
$0
$0.26 P/Share
|
|
Jun 09
2022
|
Ronald S. Altbach Director |
SELL
Open market or private sale
|
Direct |
888
-0.36%
|
$0
$0.44 P/Share
|
|
Jun 09
2022
|
Ronald S. Altbach Director |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+44.44%
|
$0
$0.01 P/Share
|
|
Mar 10
2022
|
Ronald S. Altbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 10
2022
|
Alan B. Bergman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+41.18%
|
-
|
|
Mar 10
2022
|
Alfonso J. Cervantes Jr Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+11.11%
|
-
|
|
Mar 10
2022
|
Richard M Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+7.51%
|
-
|
|
Mar 10
2022
|
Darren C. Minton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+6.9%
|
-
|
|
Mar 10
2022
|
Robert S. Rein Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.89%
|
-
|
|
Mar 10
2022
|
Roger Conley Wood Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 10
2022
|
Ryan F. Zackon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+20.28%
|
-
|
|
Feb 18
2022
|
Richard M Cohen Director |
BUY
Other acquisition or disposition
|
Direct |
16,000
+2.75%
|
-
|
|
Feb 18
2022
|
Robert S. Rein Director |
BUY
Other acquisition or disposition
|
Direct |
36,000
+3.0%
|
-
|
Last 12 Months Summary
| Open market or private purchase | 41.7K shares |
|---|
| Open market or private sale | 68.9K shares |
|---|